Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 15, 2023
Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric HemorrhageMary Yurashevich, Morgan Rosser, Maria Small, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 4, 2020
Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis RulesJean Marie Vianney Sebajuri, Urania Magriples, Maria Small, et al.Journal of Bone and Mineral Metabolism|January 25, 2014
Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal womenShinichi Nagase, Michiyo Ohyama, Yoshitaka Hashimoto, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 22, 2022
Sonographic Evaluation of the Placenta in Fontan Patients: A Case SeriesRachael Putman, Sarah A Goldstein, Brita Boyd, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2013
Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN studyRichard Eastell, Shinichi Nagase, Maria Small, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2013
The effect of the cathepsin K inhibitor ONO-5334 on trabecular and cortical bone in postmenopausal osteoporosis: the OCEAN studyKlaus Engelke, Shinichi Nagase, Thomas Fuerst, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2011
Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN studyRichard Eastell, Shinichi Nagase, Michiyo Ohyama, et al.Journal of Clinical Pharmacology|October 12, 2013
Population pharmacokinetic and pharmacodynamic modeling of different formulations of ONO-5334, cathepsin K inhibitor, in Caucasian and Japanese postmenopausal femalesChihiro Hasegawa, Tomoya Ohno, Takeo Umemura, et al.American Journal of Perinatology|November 28, 2021
Risk Factors for Adverse Maternal Outcomes following Expectantly Managed Preterm Prelabor Rupture of MembranesAlice J Darling, Hailey M Harris, Gregory E Zemtsov, et al.Journal of Clinical Pharmacology|March 12, 2014
Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosisChihiro Hasegawa, Helen Kastrissios, Jonathan Monteleone, et al.Pageof 4